The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Regulation of Renal Fatty Acid and Cholesterol Metabolism, Inflammation, and Fibrosis in Akita and OVE26 Mice With Type 1 Diabetes
Open accessAbstract
In Akita and OVE26 mice, two genetic models of type 1 diabetes, diabetic nephropathy is characterized by mesangial expansion and loss of podocytes, resulting in glomerulosclerosis and proteinuria, and is associated with increased expression of profibrotic growth factors, proinflammatory cytokines, and increased oxidative stress. We have also found significant increases in renal triglyceride and cholesterol content. The increase in renal triglyceride content is associated with 1) increased expression of sterol regulatory element–binding protein (SREBP)-1c and carbohydrate response element–binding protein (ChREBP), which collectively results in increased fatty acid synthesis, 2) decreased expression of peroxisome proliferator–activated receptor (PPAR)-α and -δ, which results in decreased fatty acid oxidation, and 3) decreased expression of farnesoid X receptor (FXR) and small heterodimer partner (SHP). The increase in cholesterol content is associated with 1) increased expression of SREBP-2 and 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase, which results in increased cholesterol synthesis, and 2) decreased expression of liver X receptor (LXR)-α, LXR-β, and ATP-binding cassette transporter-1, which results in decreased cholesterol efflux. Our results indicate that in type 1 diabetes, there is altered renal lipid metabolism favoring net accumulation of triglycerides and cholesterol, which are driven by increases in SREBP-1, ChREBP, and SREBP-2 and decreases in FXR, LXR-α, and LXR-β, which may also play a role in the increased expression of profibrotic growth hormones, proinflammatory cytokines, and oxidative stress.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339
Inflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
Sinal, C. J., Tohkin, M., Miyata, M., Ward, J. M., Lambert, G., & Gonzalez, F. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00062-3 · Cited by 1,819
Protein Sensors for Membrane Sterols
Goldstein, J. L., DeBose-Boyd, R. A., & Brown, M. S. (2006) · Cell · doi:10.1016/j.cell.2005.12.022 · Cited by 1,517
Structural-functional relationships in diabetic nephropathy.
Mauer, S. M., Steffes, M. W., Ellis, E. N., Sutherland, D. E., Brown, D. M., & Goetz, F. C. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111523 · Cited by 1,209
Susztak, K., Raff, A. C., Schiffer, M., & Böttinger, E. P. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-0894 · Cited by 1,096
Podocyte loss and progressive glomerular injury in type II diabetes.
Pagtalunan, M. E., Miller, P. L., Jumping-Eagle, S., Nelson, R. G., Myers, B. D., Rennke, H. G., Coplon, N. S., Sun, L., & Meyer, T. W. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119163 · Cited by 1,088
LIPID NEPHROTOXICITY IN CHRONIC PROGRESSIVE GLOMERULAR AND TUBULO-INTERSTITIAL DISEASE
Moorhead, J. F., El-Nahas, M., Chan, M. K., & Varghese, Z. (1982) · The Lancet · doi:10.1016/s0140-6736(82)91513-6 · Cited by 1,070
Liver X receptors as integrators of metabolic and inflammatory signaling
Zelcer, N. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27883 · Cited by 978
Sorting out the roles of PPAR in energy metabolism and vascular homeostasis
Lefebvre, P. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27989 · Cited by 962
Effect of lipid reduction on the progression of renal disease: A meta-analysis
Fried, L. F., Orchard, T. J., & Kasiske, B. L. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00487.x · Cited by 672
Intercapillary Lesions in the Glomeruli of the Kidney.
Kimmelstiel, P., & Wilson, C. (1936) · PubMed · Cited by 661
PPAR : a dagger in the heart of the metabolic syndrome
Barish, G. D. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27955 · Cited by 641
LXRS AND FXR: The Yin and Yang of Cholesterol and Fat Metabolism
Kalaany, N. Y., & Mangelsdorf, D. J. (2006) · Annual Review of Physiology · doi:10.1146/annurev.physiol.68.033104.152158 · Cited by 615
Wang, J., Takeuchi, T., Tanaka, S., Kubo, S.-K., Kayo, T., Lu, D., Takata, K., Koizumi, A., & Izumi, T. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4431 · Cited by 571
From the Periphery of the Glomerular Capillary Wall Toward the Center of Disease
Wolf, G., Chen, S., & Ziyadeh, F. N. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1626 · Cited by 565
Cellular Pathology As Based upon Physiological and Pathological Histology.
(1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-1-157_2 · Cited by 455
Miyazaki, M., Kim, Y.-C., Gray-Keller, M. P., Attie, A. D., & Ntambi, J. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005488200 · Cited by 449
Dentin, R., Pégorier, J.-P., Benhamed, F., Foufelle, F., Ferré, P., Fauveau, V., Magnuson, M. A., Girard, J., & Postic, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312475200 · Cited by 444
Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription
Ishii, S., IIzuka, K., Miller, B. C., & Uyeda, K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405238101 · Cited by 416
Glomerular cell number in normal subjects and in type 1 diabetic patients
Steffes, M. W., Schmidt, D., Mccrery, R., & Basgen, J. M. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00725.x · Cited by 408
Liu, Y., Binz, J., Numerick, M. J., Dennis, S., Luo, G., Desai, B., MacKenzie, K. I., Mansfield, T. A., Kliewer, S. A., Goodwin, B., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18945 · Cited by 398
Jiang, T., Wang, Z., Proctor, G., Moskowitz, S., Liebman, S. E., Rogers, T., Lucia, M. S., Li, J., & Levi, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500801200 · Cited by 387
Self-citationSun, L., Halaihel, N., Zhang, W., Rogers, T., & Levi, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110650200 · Cited by 333
Self-citationWang, Z., Jiang, T., Li, J., Proctor, G., McManaman, J. L., Lucia, S., Chua, S., & Levi, M. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2328 · Cited by 303
Self-citationCellular Lipid Metabolism and the Role of Lipids in Progressive Renal Disease
Abrass, C. K. (2004) · American Journal of Nephrology · doi:10.1159/000075925 · Cited by 279
Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression
Claudel, T., Inoue, Y., Barbier, O., Duran-Sandoval, D., Kosykh, V., Fruchart, J., Fruchart, J.-C., Gonzalez, F. J., & Staels, B. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00896-5 · Cited by 268
Christiansen-Weber, T. A., Voland, J. R., Wu, Y., Ngo, K., Roland, B. L., Nguyen, S., Peterson, P. A., & Fung-Leung, W.-P. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64614-7 · Cited by 235
Stoeckman, A. K., Ma, L., & Towle, H. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311301200 · Cited by 218
The LXR ligand T0901317 induces severe lipogenesis in the db/db diabetic mouse
Chisholm, J. W., Hong, J., Mills, S. A., & Lawn, R. M. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300135-jlr200 · Cited by 192
Miao, B., Zondlo, S., Gibbs, S., Cromley, D., Hosagrahara, V. P., Kirchgessner, T. G., Billheimer, J., & Mukherjee, R. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300450-jlr200 · Cited by 186
Fiorucci, S., Rizzo, G., Antonelli, E., Renga, B., Mencarelli, A., Riccardi, L., Orlandi, S., Pruzanski, M., Morelli, A., & Pellicciari, R. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.084905 · Cited by 183
SREBPs: sterol-regulated transcription factors
Espenshade, P. J. (2006) · Journal of Cell Science · doi:10.1242/jcs.02866 · Cited by 171
Development of Late-Stage Diabetic Nephropathy in OVE26 Diabetic Mice
Zheng, S., Noonan, W. T., Metreveli, N. S., Coventry, S., Kralik, P. M., Carlson, E. C., & Epstein, P. N. (2004) · Diabetes · doi:10.2337/diabetes.53.12.3248 · Cited by 165
Repression of Farnesoid X Receptor during the Acute Phase Response
Kim, M. S., Shigenaga, J. K., Moser, A., Feingold, K. R., & Grünfeld, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212633200 · Cited by 157
Accelerated Diabetic Nephropathy in Mice Lacking the Peroxisome Proliferator–Activated Receptor α
Park, C. W., Kim, H. W., Ko, S., Chung, H. W., Lim, S. W., Yang, C. W., Chang, Y. S., Sugawara, A., Guan, Y., & Breyer, M. D. (2006) · Diabetes · doi:10.2337/diabetes.55.04.06.db05-1329 · Cited by 149
Gene-selective modulation by a synthetic oxysterol ligand of the liver X receptor
Quinet, E. M., Savio, D. A., Halpern, A. R., Chen, L., Miller, C. P., & Nambi, P. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400257-jlr200 · Cited by 144
Petermann, A. T., Pippin, J. W., Krofft, R. D., Blonski, M. J., Griffin, S., Durvasula, R. V., & Shankland, S. J. (2004) · Nephron Experimental Nephrology · doi:10.1159/000081555 · Cited by 131
Jiang, T., Liebman, S. E., Lucia, M. S., Li, J., & Levi, M. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00733.x · Cited by 123
Self-citationSiu, B., Saha, J., Smoyer, W. E., Sullivan, K. A., & Brosius, F. C. (2006) · BMC Nephrology · doi:10.1186/1471-2369-7-6 · Cited by 115
Javor, E. D., Moran, S. A., Young, J. R., Cochran, E. K., DePaoli, A. M., Oral, E. A., Turman, M. A., Blackett, P. R., Savage, D. B., O’Rahilly, S., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032140 · Cited by 114
He, Z., Jiang, T., Wang, Z., Levi, M., & Li, J. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00568.2003 · Cited by 85
Self-citationJiang, T., Liebman, S. E., Lucia, M. S., Phillips, C. L., & Levi, M. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004080701 · Cited by 84
Self-citationWang, Y., Moser, A. H., Shigenaga, J. K., Grünfeld, C., & Feingold, K. R. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500134-jlr200 · Cited by 82
Bruneval, P., Bariéty, J., Bélair, M.-F., Mandet, C., Heudes, D., & Nicoletti, A. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.12.2099 · Cited by 60
Zhu, X., Herzenberg, A. M., Eskandarian, M. R., Maguire, G. F., Scholey, J. W., Connelly, P. W., & Ng, D. S. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63386-x · Cited by 44
Ruan, X. Z., Moorhead, J. F., Fernando, R. L., Wheeler, D. C., Powis, S. H., & Varghese, Z. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320088 · Cited by 43
Cited by
Kang, H. M., Ahn, S. H., Choi, P., Ko, Y.-A., Han, S. H., Chinga, F., Park, A. S. D., Tao, J., Sharma, K., Pullman, J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3762 · Cited by 1,555
Mitochondrial energetics in the kidney
Bhargava, P., & Schnellmann, R. G. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.107 · Cited by 1,334
SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology
Shimano, H., & Sato, R. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.91 · Cited by 1,174
Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis
D'Agati, V. D., Chagnac, A., de Vries, A. P. J., Levi, M., Porrini, E., Herman-Edelstein, M., & Praga, M. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.75 · Cited by 716
Self-citationAltered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy
Herman-Edelstein, M., Scherzer, P., Tobar, A., Levi, M., & Gafter, U. (2014) · Journal of Lipid Research · doi:10.1194/jlr.p040501 · Cited by 645
Self-citation
Metadata
- Authors
- Proctor, G., Jiang, T., Iwahashi, M., Wang, Z., Li, J., & Levi, M.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2006-09-01
- Volume
- 55
- Issue
- 9
- Pages
- 2502-2509
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2148718682
- Cited by
- 303
- References
- 47
- FWCI
- 6.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.